(2R,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13R,14S,17S)-17-[(1S)-1-[(2R,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxyethyl]-14-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol

Details

Top
Internal ID 2f4d2456-599e-4e9e-ad7a-fb41ed7c044d
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name (2R,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13R,14S,17S)-17-[(1S)-1-[(2R,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxyethyl]-14-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol
SMILES (Canonical) CC1C(C(CC(O1)OC(C)C2CCC3(C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)C)O)OC)O)C)C)O)O)O
SMILES (Isomeric) C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H](C)[C@H]2CC[C@]3([C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)C)O)OC)O)C)C)O)O)O
InChI InChI=1S/C34H56O10/c1-17(41-26-16-25(35)27(36)18(2)42-26)22-11-14-34(39)24-8-7-20-15-21(9-12-32(20,4)23(24)10-13-33(22,34)5)44-31-29(38)30(40-6)28(37)19(3)43-31/h7,17-19,21-31,35-39H,8-16H2,1-6H3/t17-,18+,19+,21-,22+,23-,24+,25+,26+,27+,28-,29+,30-,31-,32-,33+,34-/m0/s1
InChI Key BZSNMVMUVDVWRW-POBLBKHBSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C34H56O10
Molecular Weight 624.80 g/mol
Exact Mass 624.38734798 g/mol
Topological Polar Surface Area (TPSA) 147.00 Ų
XlogP 2.30
Atomic LogP (AlogP) 2.81
H-Bond Acceptor 10
H-Bond Donor 5
Rotatable Bonds 6

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13R,14S,17S)-17-[(1S)-1-[(2R,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxyethyl]-14-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8695 86.95%
Caco-2 - 0.8502 85.02%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability - 0.6571 65.71%
Subcellular localzation Mitochondria 0.6100 61.00%
OATP2B1 inhibitior - 0.7212 72.12%
OATP1B1 inhibitior + 0.8922 89.22%
OATP1B3 inhibitior + 0.9121 91.21%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.7321 73.21%
BSEP inhibitior - 0.6877 68.77%
P-glycoprotein inhibitior + 0.6761 67.61%
P-glycoprotein substrate + 0.7194 71.94%
CYP3A4 substrate + 0.7175 71.75%
CYP2C9 substrate - 0.7962 79.62%
CYP2D6 substrate - 0.8413 84.13%
CYP3A4 inhibition - 0.9447 94.47%
CYP2C9 inhibition - 0.9061 90.61%
CYP2C19 inhibition - 0.9022 90.22%
CYP2D6 inhibition - 0.9344 93.44%
CYP1A2 inhibition - 0.8625 86.25%
CYP2C8 inhibition + 0.5929 59.29%
CYP inhibitory promiscuity - 0.9467 94.67%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5531 55.31%
Eye corrosion - 0.9899 98.99%
Eye irritation - 0.9333 93.33%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9253 92.53%
Ames mutagenesis - 0.7854 78.54%
Human Ether-a-go-go-Related Gene inhibition + 0.6941 69.41%
Micronuclear - 0.7700 77.00%
Hepatotoxicity - 0.6801 68.01%
skin sensitisation - 0.8607 86.07%
Respiratory toxicity + 0.7778 77.78%
Reproductive toxicity + 0.9667 96.67%
Mitochondrial toxicity + 0.8250 82.50%
Nephrotoxicity - 0.8686 86.86%
Acute Oral Toxicity (c) II 0.3319 33.19%
Estrogen receptor binding + 0.6781 67.81%
Androgen receptor binding + 0.7271 72.71%
Thyroid receptor binding - 0.5956 59.56%
Glucocorticoid receptor binding + 0.5924 59.24%
Aromatase binding + 0.6476 64.76%
PPAR gamma + 0.5701 57.01%
Honey bee toxicity - 0.6973 69.73%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity + 0.5451 54.51%
Fish aquatic toxicity + 0.9216 92.16%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.51% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.84% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.60% 91.11%
CHEMBL5608 Q16288 NT-3 growth factor receptor 92.94% 95.89%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 91.00% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 90.59% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.12% 100.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 88.64% 95.89%
CHEMBL226 P30542 Adenosine A1 receptor 88.42% 95.93%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.84% 86.33%
CHEMBL2581 P07339 Cathepsin D 87.82% 98.95%
CHEMBL1806 P11388 DNA topoisomerase II alpha 87.77% 89.00%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.41% 97.14%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 85.53% 91.07%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.44% 85.14%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 83.65% 94.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.24% 90.71%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 82.21% 97.33%
CHEMBL2959 Q08881 Tyrosine-protein kinase ITK/TSK 81.90% 95.00%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 81.04% 100.00%
CHEMBL3492 P49721 Proteasome Macropain subunit 80.90% 90.24%
CHEMBL4208 P20618 Proteasome component C5 80.30% 90.00%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 80.02% 89.05%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Periploca graeca

Cross-Links

Top
PubChem 21593969
LOTUS LTS0208836
wikiData Q104950669